Stock MoversStock Movers

Kingfisher Soars, Roche's Shot, Ericsson's Slip

View descriptionShare
 

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Kingfisher shares rise as much as 11%, the most in a year, after the B&Q and Screwfix owner posted a first-half earnings beat and lifted its full-year profit guidance beyond analyst expectations.
- Roche Holding’s experimental obesity shot enicepatide cut both blood sugar and body weight in type-2 diabetes patients who were overweight or obese in a mid-stage trial.
- Ericsson slips as much as 3.9%, the most since mid July, after Morgan Stanley downgrades the Swedish mobile networks and technology group to underweight from equal-weight, saying margins are “inflecting to the downside.”

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Su 
Social links
Follow podcast
Recent clips
Browse 3,049 clip(s)